Urogen Pharma (URGN)
(Delayed Data from NSDQ)
$16.39 USD
-0.27 (-1.62%)
Updated Jul 10, 2024 04:00 PM ET
After-Market: $16.40 +0.01 (0.06%) 4:22 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 27% (68 out of 250)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.40 | 1.35 | 9.99 |
Current Quarter Estimate | -0.84 | 7.43 | 61.00 |
Year Ago Quarter Estimate | -1.03 | 0.12 | 54.84 |
Next Quarter Estimate | -0.82 | 7.81 | 63.00 |
Next Year Estimate | -2.52 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 0.85 | 15.60 | 15.67 |
Next Year | 28.41 | 9.80 | 9.31 |
Last 5 Years | NA | 3.70 | 8.10 |
Next 5 Years | NA | 20.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | NA | 1.88 |
Price/Cash Flow (MRFY) | NA | 15.95 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -123.74% | -100.57% |
Return on Equity (TTM) | NA | -21.50% |
Debt to Equity (MRQ) | NA | 0.13 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.